| To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer Condition: Head and Neck Neoplasms Intervention: Drug: SCB01A Sponsor: SynCore Biotechnology Co., Ltd. Terminated |
| Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer Condition: Head and Neck Cancer Intervention: Drug: Panitumumab + paclitaxel Sponsors: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello; Amgen; Trial Form Support S.L. Completed |
| The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD) Conditions: Head and Neck Neoplasms; Hearing Loss Intervention: Sponsor: University of Manchester Not yet recruiting |
| A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients Condition: Head and Neck Cancer Intervention: Biological: PepCan Sponsor: University of Arkansas Not yet recruiting |
| NUTRI-HAB - Posttreatment Rehabilitation of Nutrition Impact Symptoms in Head and Neck Cancer Survivors Condition: Head and Neck Cancer Intervention: Other: NUTRI-HAB Sponsors: Odense University Hospital; REHPA The Danish Knowledge Centre for rehabilitation and Palliative Care; University of Southern Denmark; University College Copenhagen; Odense Patient Data Explorative Network; Rigshospitalet, Denmark Enrolling by invitation |
| Comparison of Endoscopic Visualization and CT Imaging of Head and Neck Cancers With Pathological Validation Study Condition: Head and Neck Cancer Intervention: Sponsor: University Health Network, Toronto Recruiting |
| A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer Condition: Head and Neck Cancer Interventions: Drug: BMX-001; Radiation: Radiation Therapy; Drug: Cisplatin Sponsors: BioMimetix JV, LLC; Duke University Recruiting |
| Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer Condition: Head and Neck Cancer Intervention: Drug: 99mTc-EC-DG Sponsor: University of Chicago Completed |
| Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients Condition: Head and Neck Cancer Interventions: Behavioral: Quality of Life Survey; Behavioral: Health Management Surveys; Other: Monitoring Devices; Behavioral: Symptoms Surveys; Behavioral: Device Usability Survey Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Active, not recruiting |
| Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema Conditions: Head and Neck Neoplasms; Head and Neck Lymphedema; Head and Neck Cancer Interventions: Device: Head and neck garments for pneumatic compression device; Drug: NIRFLI with ICG Sponsor: Tactile Medical Completed |
Δευτέρα 22 Απριλίου 2019
ClinicalTrials : Head and Neck Neoplasms
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Chronic exposure to high altitude may lead to hyperuricemia. We investigated the prevalence of hyperuricemia and its risk factors...
-
Publication date: Available online 6 October 2018 Source: The Journal of Emergency Medicine Author(s): Abdallah Rebeiz, Roula Sasso, Rana...
-
Abstract Background and Objectives Subdural hematoma (SDH) is the most common form of traumatic intracranial hemorrhage. Severity of dis...
-
Journal of Cranio-Maxillofacial Surgery from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2vEXdjS
-
http://bit.ly/2saJoKg
-
Publication date: Available online 17 January 2018 Source: The Journal of Emergency Medicine Author(s): Jason M. Block, Chris F. Allison,...
-
Abstract Objectives Tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) is a member of the TNF super-family, which is involv...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου